SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-013429
Filing Date
2023-08-04
Accepted
2023-08-04 16:30:38
Documents
68
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tgtx-20230630x10q.htm   iXBRL 10-Q 1750062
2 EX-10.1 tgtx-20230630xex10d1.htm EX-10.1 639108
3 EX-31.1 tgtx-20230630xex31d1.htm EX-31.1 13517
4 EX-31.2 tgtx-20230630xex31d2.htm EX-31.2 13484
5 EX-32.1 tgtx-20230630xex32d1.htm EX-32.1 6651
6 EX-32.2 tgtx-20230630xex32d2.htm EX-32.2 6589
  Complete submission text file 0001558370-23-013429.txt   6930214

Data Files

Seq Description Document Type Size
7 EX-101.SCH tgtx-20230630.xsd EX-101.SCH 49687
8 EX-101.CAL tgtx-20230630_cal.xml EX-101.CAL 53346
9 EX-101.DEF tgtx-20230630_def.xml EX-101.DEF 165767
10 EX-101.LAB tgtx-20230630_lab.xml EX-101.LAB 381983
11 EX-101.PRE tgtx-20230630_pre.xml EX-101.PRE 287105
62 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20230630x10q_htm.xml XML 796769
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 231144460
SIC: 2834 Pharmaceutical Preparations